Japan · Delayed Price · Currency is JPY Genetec Statistics
Total Valuation
Genetec has a market cap or net worth of JPY 5.06 billion. The enterprise value is 5.50 billion.
| Market Cap | 5.06B |
| Enterprise Value | 5.50B |
Important Dates
The last earnings date was Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | Mar 30, 2026 |
Share Statistics
Genetec has 11.55 million shares outstanding. The number of shares has increased by 0.10% in one year.
| Current Share Class | 11.55M |
| Shares Outstanding | 11.55M |
| Shares Change (YoY) | +0.10% |
| Shares Change (QoQ) | +0.32% |
| Owned by Insiders (%) | 71.03% |
| Owned by Institutions (%) | n/a |
| Float | 2.98M |
Valuation Ratios
The trailing PE ratio is 15.87.
| PE Ratio | 15.87 |
| Forward PE | n/a |
| PS Ratio | 0.55 |
| PB Ratio | 2.11 |
| P/TBV Ratio | 4.24 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 168.59 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.07, with an EV/FCF ratio of -152.91.
| EV / Earnings | 17.15 |
| EV / Sales | 0.60 |
| EV / EBITDA | 8.07 |
| EV / EBIT | 11.30 |
| EV / FCF | -152.91 |
Financial Position
The company has a current ratio of 1.45, with a Debt / Equity ratio of 0.88.
| Current Ratio | 1.45 |
| Quick Ratio | 1.22 |
| Debt / Equity | 0.88 |
| Debt / EBITDA | 3.09 |
| Debt / FCF | -58.56 |
| Interest Coverage | 23.19 |
Financial Efficiency
Return on equity (ROE) is 13.82% and return on invested capital (ROIC) is 7.55%.
| Return on Equity (ROE) | 13.82% |
| Return on Assets (ROA) | 5.35% |
| Return on Invested Capital (ROIC) | 7.55% |
| Return on Capital Employed (ROCE) | 13.20% |
| Revenue Per Employee | 14.93M |
| Profits Per Employee | 518,578 |
| Employee Count | 619 |
| Asset Turnover | 1.62 |
| Inventory Turnover | 28.04 |
Taxes
In the past 12 months, Genetec has paid 165.00 million in taxes.
| Income Tax | 165.00M |
| Effective Tax Rate | 33.95% |
Stock Price Statistics
The stock price has decreased by -18.03% in the last 52 weeks. The beta is 0.82, so Genetec's price volatility has been lower than the market average.
| Beta (5Y) | 0.82 |
| 52-Week Price Change | -18.03% |
| 50-Day Moving Average | 463.32 |
| 200-Day Moving Average | 478.87 |
| Relative Strength Index (RSI) | 43.29 |
| Average Volume (20 Days) | 35,870 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Genetec had revenue of JPY 9.24 billion and earned 321.00 million in profits. Earnings per share was 27.60.
| Revenue | 9.24B |
| Gross Profit | 3.53B |
| Operating Income | 487.00M |
| Pretax Income | 486.00M |
| Net Income | 321.00M |
| EBITDA | 682.00M |
| EBIT | 487.00M |
| Earnings Per Share (EPS) | 27.60 |
Balance Sheet
The company has 1.66 billion in cash and 2.11 billion in debt, giving a net cash position of -447.00 million or -38.71 per share.
| Cash & Cash Equivalents | 1.66B |
| Total Debt | 2.11B |
| Net Cash | -447.00M |
| Net Cash Per Share | -38.71 |
| Equity (Book Value) | 2.39B |
| Book Value Per Share | 207.44 |
| Working Capital | 1.25B |
Cash Flow
In the last 12 months, operating cash flow was 30.00 million and capital expenditures -66.00 million, giving a free cash flow of -36.00 million.
| Operating Cash Flow | 30.00M |
| Capital Expenditures | -66.00M |
| Free Cash Flow | -36.00M |
| FCF Per Share | -3.12 |
Margins
Gross margin is 38.24%, with operating and profit margins of 5.27% and 3.47%.
| Gross Margin | 38.24% |
| Operating Margin | 5.27% |
| Pretax Margin | 5.26% |
| Profit Margin | 3.47% |
| EBITDA Margin | 7.38% |
| EBIT Margin | 5.27% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 19.50, which amounts to a dividend yield of 4.47%.
| Dividend Per Share | 19.50 |
| Dividend Yield | 4.47% |
| Dividend Growth (YoY) | 8.33% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 63.86% |
| Buyback Yield | -0.10% |
| Shareholder Yield | 4.38% |
| Earnings Yield | 6.35% |
| FCF Yield | -0.71% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 28, 2023. It was a forward split with a ratio of 3.
| Last Split Date | Dec 28, 2023 |
| Split Type | Forward |
| Split Ratio | 3 |
Scores
Genetec has an Altman Z-Score of 3.1 and a Piotroski F-Score of 3.
| Altman Z-Score | 3.1 |
| Piotroski F-Score | 3 |